Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center

Contrary to previous reports, we have found that other side effects besides impulse control behavioral disorders also increase risk for developing DAWS. Furthermore, the prevalence of DAWS did not differ between partial versus total discontinuation of the dopamine agonist.